Valuation

FMEFresenius Medical Care AG

StockXetraGermanyHealth careEU retail: available

+0.1% today · −9.2% over a year

7/10 A 1–10 summary of how an instrument compares with similar ones (same sector and region) by published rules. It describes today's data; it is not a price forecast. More in the glossary → «Balanced» — higher than 72% of the instruments we score

Priced lower than most peers. Dividend yield 3.67%.

Fresenius Medical Care AG (FME) valuation against sector peers: P/E 11.6 (sector median 22.4), P/B 0.9, EV/EBIT 11.5, P/S 0.6.

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricFMESector medianvs median
P/E11.622.4 · n=2848% below
P/B0.93.6 · n=4576% below
P/S0.64.5 · n=4087% below
EV/EBIT11.520.8 · n=2845% below
Free-cash-flow yield—3.5% · n=41—
Dividend yield3.67%0.12% · n=1002,971% above
Return on equity7.0%6.8% · n=56near the median
Return on invested capital6.1%7.0% · n=4713% below
Gross margin25.6%70.2% · n=3963% below
Net debt / EBITDA2.661.39 · n=2691% above

Value factor: 98 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

NVSNovartis AG21.36.517.95.9%2.5%9/10
NOVNNovartis AG21.26.417.85.9%2.9%10/10
AZNAstraZeneca plc25.75.420.94.5%1.9%6/10
AZNAstraZeneca PLC25.75.420.94.5%1.3%6/10
NVONovo Nordisk A/S11.25.99.85.2%4.8%7/10
GSKGSK plc13.84.811.38.1%3.7%10/10
SNYSanofi11.81.316.37.8%5.0%7/10
SANSanofi SA11.81.316.27.8%5.5%8/10
TEVATeva Pharmaceutical Industries Limited66.06.037.22.9%0.0%6/10
ALCAlcon34.71.527.35.1%0.4%4/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 31 Dec 2025 · filed 24 Feb 2026